Gut health boosts cancer therapy: new trial tests postbiotics for head and neck cancer
NCT ID NCT07485296
First seen Mar 23, 2026 · Last updated May 24, 2026 · Updated 9 times
Summary
This study tests whether a special supplement called a postbiotic can reduce side effects and improve the immune response in people with advanced head and neck cancer who are receiving standard immunotherapy (pembrolizumab). About 45 participants will receive either the postbiotic or a placebo alongside their cancer treatment. The goal is to see if the supplement changes gut and mouth bacteria in a way that helps the body handle immunotherapy better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD & NECK SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Istituto Clinico Humanitas
RECRUITINGRozzano, Milano, 20089, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.